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Available online 29 February 2008Tetratricopeptide (TPR)-domain proteins are involved in various cellular processes. The TPR domain is known
to be responsible for interaction with other proteins commonly recognizing sequence motifs at the C-termini.
One such TPR-protein, TRIP8b, was originally identiﬁed in rat as an interaction partner of Rab8b, and its
human orthologue as a protein related to the peroxisomal targeting signal 1 (PTS1) receptor Pex5p (Pex5Rp).
Somewhat later, the mouse orthologue was reported to bind the hyperpolarization-activated, cyclic
nucleotide-regulated HCN channels, and, very recently, the rat orthologue was shown to interact with
latrophilin 1, the calcium-independent receptor of α-latrotoxin. Here we employed various methodological
approaches to investigate and compare the binding speciﬁcities of the human PTS1 receptor Pex5p and the
related protein Pex5Rp/TRIP8b towards a subset of targets, including Rab8b and various C-termini resembling
PTS1. The results show that the TPR domains of Pex5p and Pex5Rp/TRIP8b have distinct but overlapping
substrate speciﬁcities. This suggests that selectivity in the recognition of substrates by the TPR domains of
Pex5p and Pex5Rp/TRIP8b is a matter of considerable complexity, and that no single determinant appears to
be sufﬁcient in unambiguously deﬁning a binding target for either protein. This idea is further corroborated by
our observations that changes in the surrounding residues or the conformational state of one of the binding
partners can profoundly alter their binding activities. The implications of these ﬁndings for the possible
peroxisome-related functions of Pex5Rp/TRIP8b are discussed.
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Proteins are composed of structural domains, and each domain
contributes a speciﬁc function to the overall role of a particular protein.
Among these structural modules the tetratricopeptide repeat (TPR)-
domain [1] is known to be responsible for interaction with other pro-
teins [2], commonly recognizing sequence motifs at the C-termini [3,4].
Although the sequence conservation among the TPRs is very low, these
motifs fold into a very similar compact conformation of two short
antiparallel alpha-helices termed A and B separated by a turn [5]. The
interaction between the adaptor protein Hop and the C-terminal end-
ings of the twomolecular chaperonesHsp70andHsp90 consistingof the
amino acid sequence – EEVD is one well-characterized example of a
protein-protein interaction involving a TPR domain [3], and APC3 andat tel.: +32 16 330114; fax: +32
: +32 16 345699.
. Fransen),
en).
epartement Rega, Sint-Maar-
l rights reserved.APC7 of the mammalian anaphase-promoting complex (APC) recogniz-
ing the C-terminal dipeptide motif – IR is another one [6].
Thebest studiedexampleof aTPRprotein interactingwithC-terminal
endings is Pex5p, a protein binding peroxisomal targeting signals (PTS1)
at the C-terminus of peroxisomal matrix proteins [7–11]. According to
the crystal structure [7,9] the PTS1 is locked in a groove with many
interactions towards side chain residues of the TPR domain. Proteins
carrying a PTS1 are recognized in the cytosol by Pex5p, and are subse-
quently imported into peroxisomes by the concerted action of a whole
range of peroxins in a manner not yet elucidated [12]. Currently it is
generally accepted that Pex5p functions as the cycling receptor for PTS1-
type matrix proteins [13]. In addition, evidence was presented that after
docking at the peroxisomal membrane, Pex5p remains bound to its
substrate and accompanies its cargo – at least partially – through the
membrane and perhaps even into the matrix [14,15]. Finally, the recep-
tor-cargo complexes are dissociated and the receptor molecules are
transported back into the cytosol to allow for another roundof transport.
In an attempt to discover factors involved in the release of PTS1
proteins from Pex5p during or after peroxisomal import, we identiﬁed a
Pex5p-related protein (Pex5Rp) in man and mouse [16]. Analysis of the
Pex5p-like protein revealed the presence of a tetratricopeptide repeat
(TPR) domain in its C-terminal half consisting of seven TPR motifs. This
Table 1
List of oligonucleotides (restriction sites are underlined)
Name Nucleotide sequence
5.E379Tfw 5′-CACCAACACGTCCCTGCAGCGACAG-3′
5.E379Trv 5′-CTGCAGGGACGTGTTGGTGAAGCTCAC-3′
5H.T407Efw 5′-TACTAACGAGGGCCATCAGCAGGATG-3′
5H.T407Erv 5′-CTGATGGCCCTCGTTAGTATAACTCACAGC-3′
DsRed-KSKLrv 5′-GGGGGCGGCCGCTCACAGTTTACTCTTCAGGAACAGGTGGTGGCG-3′
DsRed-RSLLrv 5′-GGGGGCGGCCGCTCACAGGAGACTCCTCAGGAACAGGTGGTGGCG-3′
EGFP-N1fw 5′-GCAGAGCTGGTTTAGTGAACCG-3′
HsRab8bF1 5′-GGGCCGGATCCAGAAGATGGCGAAGACG-3′
HsRab8bF2 5′-CTCTCTGGATCCATGGCGAAGACGTACGATTATC-3′
HsRab8bR1 5′-CTCTCTCTGCAGTTCATCAAAGTAGCGAGC-3′
HsRab8bR2 5′-CTCTCTCTGCAGCTAGCAACGAAAGAAACTG-3′
HsRab8bR3 5′-CTCTCTCTGCAGTTCATCAAAGTAGCGAGGAAC-3′
PeptF1 5′-GGTCCAGATCTTCCTAGAACTAGTGGATCC-3′
PeptF2 5′-GGTCCAGATCTATCCTAGAACTAGTGGATCC-3′
PeptR1 5′-CAAAACTGCAGCCTCGAGGTCGACGGTATCG-3′
Pex5.2 5′-GCCCGTCGACCTGTCACTGGGGCAGGCCAAAC -3′
Pex5.31 5′-GGGAGATCTATGGCAATGCGGGAGCTGGTG-3′
PEX5H1 5′-GGGAATTCAAGATGCAAGCAGAATGGG-3′
PEX5H2 5′-GGGAGATCTTCAAGGATCCAAGTTGAAAGC-3′
Pex5H.F8 5′-GGGGAATTCATGTACCAGGGACACATG-3′
Pex5H.R1 5′-GGGGGTCGACTCAAGGATCCAAGTTGAAAGCTC-3′
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domain of human Pex5p. Like Pex5p, Pex5Rp recognizes C-termini of
proteins [16]. Nevertheless, Pex5p and Pex5Rp are no functional
homologues, and Pex5Rp is almost exclusively expressed in brain [16].
Simultaneously with our description of human andmouse Pex5Rp,
Chen et al. [17] reported the identiﬁcation of the rat orthologue of
Pex5Rp which was described by them as a TPR-containing Rab8b-
interacting protein (TRIP8b). Rab8b – primarily expressed in brain,
testis and spleen in rat [18] – belongs to the Rab family of small GTP-
binding proteins that play a role in vesicle transport [19]. Rab8b
contains a prenylation site at its C-terminus (CSLL) enabling it to
interact with membranes [18]. Localization studies in AtT-20 neu-
roendocrine cells revealed that TRIP8b is localized in the cytosol as
well as on some ill-deﬁned small vesicular structures, and the peri-
pheral association of TRIP8b with these membrane structures is
thought to occur through a direct interaction with Rab8b. In AtT-20
neuroendocrine cells, Rab8b partially co-localizes with adrenocorti-
cotropic hormone (ACTH), in particular at the perinuclear region and
cell tips where release of ACTH vesicles occurs. As overexpression of
Rab8b or TRIP8b stimulated ACTH release, a role for TRIP8b in regu-
lated secretion was proposed [17]. More recently, it has been reported
that mouse TRIP8b speciﬁcally interacts with all four hyperpolariza-
tion-activation cyclic nucleotide-modulated (HCN) channels through a
conserved sequence in their C-terminal tails [20]. Moreover, it has
been shown that TRIP8b alters the trafﬁcking of these channels when
heterologously expressed in human embryonic kidney 293 cells [20],
and that the distribution of TRIP8b is altered in brain of mice lack-
ing HCN1 [20]. These observations suggest a possible role for TRIP8b
in regulating HCN channel density in the plasma membrane [20].
Very recently, TRIP8b has been reported to interact directly with the
C-terminal fragment of latrophilin 1, the calcium-independent
receptor of α-latrotoxin [21]. This observation further supports the
idea that TRIP8b may determine the speciﬁcity of latrophilin 1 trans-
port from the plasma membrane to endosomes, and, therefore, re-
gulate the receptor concentration on the cell surface [21].
Chen et al. did not ﬁnd any in vitro interaction of rat TRIP8b with a
GST fusion protein ending either in the C terminal tripeptide SLL (of
Rab8b) or SKL (the prototypic PTS1) [17]. In addition, these authors
reported that the interaction of TRIP8b with (rat) Rab8b can occur in
the absence of its C-terminal tripeptide SLL [17]. In contrast, we have
shown that human Pex5Rp can bind to PTS1 ligands [16]. Also SNL, the
C-terminus of mouse HCN1 and responsible for the interaction with
mouse TRIP8b [20], is known to be a PTS1 [22]. To gain more insight
into a number of these issues, we investigated in detail the interaction
of human Pex5Rp/TRIP8b, generally referred to as Pex5Rp in this
paper, with C-terminal endings and with human Rab8b (HsRab8b) in
particular.
2. Materials and methods
2.1. Cell lines, strains and antibodies
Chinese hamster ovary (CHO) cells and control and Pex5−/− mouse ﬁbroblasts were
cultured as described [16,23]. The Escherichia coli strain Top10F′ (Invitrogen) was used
for all DNA manipulations as well as for the expression of recombinant proteins. Yeast
two-hybrid assays were performed using the Saccharomyces cerevisiae strain SFY526
(Clontech). The mouse anti-(His)6 and anti-FLAG M2 monoclonal antibodies were
purchased from Clontech and Sigma, respectively. The rabbit polyclonal antisera raised
against GST and human Pex14p are described elsewhere [24].
2.2. Cloning and expression of recombinant human Rab8b
The cDNA clone CS0DD009YM15 (accession number AL530175) (Invitrogen)was used
as a template to generate (His)6-tagged expression constructs of human Rab8b and Rab8b
mutants byPCRusing theprimersHsRab8bF1/HsRab8bR1 for (His)6-HsRab8bWT (pLA190),
HsRab8bF1/HsRab8bR2 for (His)6-HsRab8bΔSLL (pLA193), and HsRab8bF1/HsRab8bR3 for
(His)6-HsRab8bC204S (pLA205) (Table 1). The respective PCR products were gel puriﬁed
and, after digestion with Bam HI and Pst I, subcloned into the Bam HI/Pst I-restricted
expression vector pQE32 (pLA190) (Qiagen) or the Bgl II/Pst I-restricted expression vector
pBADHisA (pLA193, pLA205) (Invitrogen). Fusion proteinswere expressed upon inductionwith 1 mM IPTG (pLA190) or 0.2% (w/v) arabinose (pLA193, pLA205) for 4 h and subse-
quently puriﬁed under denaturing conditions using Ni-NTA agarose (Amersham Bio-
sciences) according to the manufacturer's instructions.
2.3. Transfections and (immuno)ﬂuorescence microscopy
ToconstructplasmidsencodingEGFP-HsRab8bWT (pLA194), EGFP-HsRab8bΔSLL (pLA195)
and EGFP-HsRab8bC204S (pLA206), the cDNAs coding for the HsRab8b fusionswere ampliﬁed
by PCR using EST clone CS0DD009YM15 as a template and the primer pairs HsRab8bF2/
HsRab8bR1, HsRab8bF2/HsRab8bR2 and HsRab8bF2/HsRab8bR3 (Table 1), respectively. The
PCR products were, after digestion with Bam HI and Pst I, subcloned into the Bgl II/Pst I-
digested pEGFP-C1 vector (Clontech). To generate pMF1479, a mammalian expression
plasmid encoding DsRed-RSLL, the corresponding cDNA was ampliﬁed by PCR (template:
pDsRed1-N1; primer pair: EGFP-N1fw and DsRed-RSLLrv), digested with Sal I/Not I, and
subcloned into the Xho I/Not I-digested pDsRed1-N1 vector (Clontech). The peroxisomal
localization of DsRed-RSLL was conﬁrmed by co-stainingwith Pex14p (data not shown). The
plasmids encoding EGFP-HsPex5Rp (pLA118) [16], HsPex5Rp-EGFP (pLA120) [16], DsRed-
KSKL (pMF578) [16,25], Flag-Pex5p [16], Flag-HsPex5Rp [16] or EGFP-KSKL (pMB1) [26] are
described elsewhere. Mammalian cells were transiently transfected by using polyethyleni-
mine (CHO cells) [27] or Lipofectamine Plus (mouse ﬁbroblasts) (Invitrogen). (Immuno)
ﬂuorescencemicroscopy studieswere performed essentially as described before [28]. Fluore-
scence was observed under a Leica DMR microscope equipped with FITC/RSGFP/Bodipy/
Fluo3/DIO and Texas Red ﬁlters, or evaluated on a CellM imaging station (Olympus)
equipped with U-MNUA2, U-MNIBA3, and U-MWIY2 ﬂuorescence mirror units.
2.4. Yeast two-hybrid analyses
The cotransformation of the bait and prey plasmids in chemically-competent SFY526
cells aswell as the liquid culture andcolony liftﬁlter assays forβ-galactosidase activitywere
performed as described in themanufacturer's instructions (Clontech). The plasmids coding
for a fusion of Gal4p activation domain (AD) to the 70 C-terminal amino acids of rat
palmitoyl-CoA oxidase (RnPCOX592–658-SKL) [29], the TPR domain of human Pex5p
(HsPex5p221–602) [29], full-length human Pex5p [30] and human Pex5Rp [16] have been
described before. Yeast expression vectors coding for AD-HsPex5pE379T (pMF1382) andAD-
HsPex5RpT407E (pMF1422)were generatedby fusionPCR (pMF1382: templatepMF106 [30],
primers Pex5.31 and 5.E379Trv (fragment 1), primers Pex5.2 and 5.E379Tfw (fragment 2);
pMF1422: template pLA134 [16], primers Pex5H.F8 and 5H.T407Erv (fragment 3), primers
5H.T407Efw and Pex5H.R1 (fragment 4)). The fragments 1 and 2 were fused and used as
template in a secondPCR reaction in combinationwith the primers Pex5.31 andPex5.2. The
fragments 3 and 4 were fused and used as a template in a second PCR reaction in com-
binationwith the primers Pex5H.F8 and Pex5H.R1. After digestionwith Bgl II and Sal I, the
fusion fragment encoding HsPex5pE379T was subcloned into the Bam HI/Sal I-digested
pGAD424 vector. The fusion fragment encoding HsPex5RpT407E was digested with Eco RI
and Sal I and subcloned into pGAD424 digested with the same restriction enzymes. A
construct encoding AD fused to the TPR domain of human Pex5Rp(321–624) (pMF341) was
made by ligating an Eco RI/Bgl II-restricted PCR product (primers: PEX5H1 and PEX5H2
(Table 1); template: I.M.A.G.E. [31] clone 1640223 (Genbank accession number AI090876)
into the Eco RI/BamHI-digested pGAD424 vector (Clontech). Plasmids coding for a selected
set of PTS1 peptides fused to the Gal4 DNA-binding domain (BD) were constructed by
ligating Bam HI/Pst I (or Bam HI/Sal I)-restricted PCR fragments (primers: PeptF1 and
PeptR1 (Table 1); templates: plasmids coding for AD-peptide fusions [32]) into theBgl II/Pst
I (or Bgl II/Sal I)-digested pGBT9 vector (Clontech). To generate constructs coding for BD-
Table 2
Pex5p and Pex5Rp display different afﬁnities for C-terminal endings in the yeast two-hybrid system
Peptide Sequence β-Galactosidase activity
HsPex5p(221–602) HsPex5p HsPex5Rp(321–624) HsPex5Rp
Sc01 CERSKL 775±351 265±89.1 24.9±2.7 28.0±13.0
Sc02 GSHRRMDATKRRESKL 447±322 66.6±44.8 2.1±0.9 b1
Sc17 WDSAVAWVPRKRVCHL b1 b1 18.5±6.6 1.9±1.2
Sc23 HQLLEWFPVYNRSTKL b1 b1 3.1±1.7 2.0±2.1
Sc26 KRVWRRQWTGRKLKL b1 b1 b1 b1
Sc27 WYGPGPGCCRRRDLKL b1 b1 b1 b1
Hs04 VVYSLLALAVQCSKL 6.8±3.0 1.1±0.4 3.8±1.3 2.3±0.9
Hs13 YRFNICDAIFQGGSRL 446±115 165±42.4 69.6±23.1 46.5±43.0
Hs19 GETMPPNNIGCTASRL 79.5±50.1 53.8±38.0 8.6±6.2 7.5±4.1
Hs31 WRIVSPYTGGSLSCKL 394±93.2 52.1±37.0 48.9±0.9 35.0±32.8
Hs35 SKVFVSGWGAGGMSRM 424±93.5 117±81.9 b1 b1
Hs50 SDTIAMNCVQVKSQL 1093±127 442±275 65.0±16.5 62.8±21.1
Hs51 MKHSWARYENIMSSQL 8.4±6.7 1.8±1.6 59.3±7.6 59.6±50.0
Hs54 SEVGTTMRGDTLTSLL 6.4±2.5 3.5±1.8 584±126 266±112
Hs55 EGGRRGMGFPAVRSLL 1824±318 583±219 1338±194 558±362
Hs56 CRSGLPCLQSLL 835±111 121±62.9 1053±160 506±154
Hs57 PEYSRAGQGTMWRSLL 535±151 64.1±51.3 569±68.2 221±121
Hs61 TEEKVVGVGGCVKSYL 165±40.9 55.7±52.2 16.8±7.7 10.0±6.0
Hs62 DGLWLGNFGVSLCSSL 12.0±2.1 3.0±1.5 178±67.0 217±130
Hs63 QGNNNGQVRDWCRPSL 21.9±19.4 9.8±7.7 124±79.6 146±57.3
Hs64 AGGRIASNCNLVSAL b1 b1 12.5±6.4 4.4±4.0
Hs65 MKLRMVVRMNPLKCVL 12.2±7.6 b1 352±36.2 145±97.8
A select set of C-terminal endings, fused to the Gal4p DNA-binding domain, were tested for interaction with HsPex5p, HsPex5p(221–602), HsPex5Rp, or HsPex5Rp(321–624), fused to
the Gal4p activation domain, in the yeast two-hybrid system. Double transformants expressing one of the bait and one of the prey fusion proteins were selected and assayed for
β-galactosidase activity using o-nitrophenyl-β-D-galactopyranoside as the substrate. The optical densitiesweremeasured at 420 nm, normalized for culture densities (optical densities
at 600 nm=10) and time (24 h), and corrected for the blank (‘empty’ plasmids only). The values given aremeans (±the standard deviation) for at least threemeasurements performed
on cultures derived from independent colonies. Pex5p (or Pex5Rp) interactions yielding a strong β-galactosidase activity (N50 normalized units) and showing a N10-fold difference in
activity (for both the full-length and the truncated forms of the protein) relative to Pex5Rp (or Pex5p) are underlined.
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respective cDNAswere ampliﬁedby PCRusingESTcloneCS0DD009YM15as a template and
the same primer pairs as described for the cloning of the (His)6-tagged fusion proteins. PCR
products were, after digestion with Bam HI and Pst I, subcloned into the Bam HI/Pst I-
digested pGBT9 vector. To generate constructs coding for BD-fusions to DsRed-KSKL
(pMF1428) or DsRed-RSLL (pMF1429), the respective cDNAs were ampliﬁed by PCR usingFig. 1. Pex5p and Pex5Rp display different speciﬁcities for GST-PTS1 fusion proteins in a
far Western assay. (A) Five µg of puriﬁed bacterially expressed GST (-), GST-
GSHRRMDATKRRESKL (Sc02; SKL), GST-SKVFVSGWGAGGMSRM (Hs35; SRM), GST-
SEVGTTMRGDTLTSLL (Hs54; SLL), or GST-DGLWLGNFGVSLCSSL (Hs62; SSL) was
subjected to SDS-PAGE and blotted onto nitrocellulose membranes. After blocking, the
blots were probed with anti-GST antibodies (α-GST), biotinylated-Pex5p(221–602) (b-5/
TPR) or biotinylated-Pex5Rp(321–624) (b-5R/TPR). Reactive complexes were identiﬁed
with goat anti-rabbit-alkaline phosphatase (AP) or streptavidin-AP conjugates. For
clarity, only the relevant portions of the blot are shown. (B) Comparison of the expres-
sion levels of b-5/TPR and b-5R/TPR. Equal amounts of the respective bacterial lysates
were subjected to SDS-PAGE and blotted onto a nitrocellulosemembrane. After blocking,
the blot was incubated with streptavidin-AP. The migration of relevant molecular mass
markers is shown on the left.pDsRed-N1 as a template in combinationwith the primer pairs EGFP-N1fw/DsRed-KSKLrv
and EGFP-N1fw/DsRed-RSLLrv, respectively. The PCR products were, after digestion with
Bgl II and Not I, subcloned into Bam HI/Not I-restricted pMF812, a pGBT9-derivative [30].
2.5. Pex5p/Pex5Rp binding experiments
In vitro interactions of recombinant (His)6-tagged Rab8b (and Rab8b variants) with
recombinant GST-tagged Pex5p and Pex5Rp fusion proteins were analyzed in a blot-
overlay assay, essentially as described before [16,33]. In vitro interactions of recombinant
GST-tagged PTS1peptideswere analyzed in a similarway, using biotinylated fusions to the
TPRdomains of Pex5p [33] or Pex5Rp [16]. TheGST-taggedPTS1 peptides Sc02, Hs35,Hs54
and Hs62 were constructed by ligating Bgl II/Sal I-restricted PCR fragments (oligonucleo-
tides: PeptF2 and PeptR1 (Table 1); templates: plasmids coding for the respective AD-
peptide fusions [32]) into the Bam HI/Sal I-digested pGEX-4T-1 vector (Amersham
Biosciences). GSTandGST-peptide fusionswere expressedupon inductionwith1mMIPTG
for 4 h and subsequently puriﬁedusing glutathione Sepharose 4B (AmershamBiosciences)
according to the manufacturer's instructions. For competition experiments, 1 μg of (His)6-
Rab8bwas coated inwells of a 96-wellmicrotiter plate and incubatedwith thebiotinylated
Pex5p or Pex5Rp fusion protein as described previously [33].Table 3
Pex5p, Pex5pE379T, Pex5Rp and Pex5RpT407E display different afﬁnities for a select set of
target proteins in the yeast two-hybrid system
BD ↓ AD → β-Galactosidase activity
HsPex5p HsPex5pE379T HsPex5Rp HsPex5RpT407E
HsRab8b b1 19.0±8.8 86.9±36.0 26.2±6.3
HsRab8bΔSLL b1 b1 b1 b1
HsRab8bC204S b1 9.8±3.5 42.2±7.3 33.5±3.6
RnPCOX592–658-SKL 403.6±52.0 153.9±20.0 185.7±10.3 222.7±21.8
DsRed-KSKL 314,1±64.7 154.7±43.9 171.5±19.6 110.5±46.6
DsRed-RSLL 262.8±31.3 255.7±52.4 283.6±58.9 147.8±10.9
Yeast transformants expressing one of the bait (BD) and one of the prey (AD) fusion
proteins were selected and assayed for β-galactosidase activity using o-nitrophenyl-β-
D-galactopyranoside as the substrate. The optical densities were measured at 420 nm,
normalized for culture densities (optical densities at 600 nm=10) and time (24 h),
and corrected for the blank ('empty' plasmids only). The values given are means (±the
standard deviation) for at least threemeasurements performed on cultures derived from
independent colonies.
Fig. 2. Pex5p and Pex5Rp display similar binding speciﬁcities for HsRab8b, HsRab8bΔSLL,
and HsRab8bC204S in a far Western assay. Puriﬁed bacterially expressed (His)6-HsRab8b
(WT), (His)6-HsRab8bΔSLL (ΔSLL), and (His)6-HsRab8bC204S (C204S) were subjected to
SDS-PAGE and blotted onto nitrocellulose membranes. After blocking, the blots were
(A) incubated with a mouse 6xHis monoclonal antibody followed by anti-mouse IgG
coupled to alkaline phosphatase, or (B) probed with the supernatant of bacterial lysates
containing GST, GST-Pex5Rp (GST-5R) or Pex5p (GST-5). GST-containing protein
complexes were identiﬁed with a rabbit anti-GST antiserum and an anti-rabbit-AP
conjugate. The migration of the 30 kDamolecular mass marker is shown on the left. The
slightly larger size of the (His)6-HsRab8bΔSLL and (His)6-HsRab8bC204S proteins is due to
the presence of 28 extraneous amino acids behind the (His)6-tag (see ‘Materials and
methods’ section).
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DNA sequencing was done by using an ALF sequencer (Amersham Biosciences) and
vector- and gene-speciﬁc primers or by sending the samples to Agowa (Germany).
Automated knowledge-based proteinmodelling was performedwith the SWISSMODEL
program at the ExPaSy proteomics server [34].
3. Results
3.1. Pex5p and Pex5Rp display different afﬁnities for C-terminal endings
Applying the two-hybrid system, we compared the binding afﬁnities
ofHsPex5pandHsPex5Rp towards a setof C-terminal endingspreviously
identiﬁed as ligands of either the human or the yeast PTS1 receptor
Pex5p among themultitude of peptides of a randomlygenerated peptide
library [32]. Since both fusion proteins consisting of the Gal4p DNA-
binding domain (BD) and the full-length Pex5p [30] or Pex5Rp (data not
shown) autoactivate the LacZ reporter gene, the interaction assays were
carried out by employing the Gal4p DNA-binding domain extended by
short C-terminal endings and the Gal4p activation domain (AD) fused toFig. 3.HsRab8b and the peptide pSKL compete for binding to Pex5p and Pex5Rp in vitro.
Microtiter wells were coated with 1 µg of puriﬁed bacterially expressed (His)6-HsRab8b
and incubated with the supernatant of a bacterial lysate containing biotinylated
HsPex5p(221–602) (squares) or biotinylated Pex5Rp(321–624) (triangles) in the presence of
increasing amounts of the peptides pSKL (CSYHKHLKPLQSKL [29]) (open symbols) or
pΔSKL (CVHESYHKHLKPLQ [29]) (closed symbols). After extensive washing, bound
Pex5p and Pex5Rp were detected photometrically with streptavidin-alkaline phospha-
tase using p-nitrophenyl phosphate as a substrate.either the full-length proteins or the respective TPR domains. This set-up
is different to the previously used one [32] and might explain quanti-
tative differences when compared.
The results of these experiments showed that AD-Pex5Rp fusion
proteins can interact with a distinct set of C-terminal endings, and the
binding speciﬁcities differ between Pex5p and Pex5Rp fused to the AD
of Gal4p (Table 2). AD-Pex5Rp showed highest afﬁnities towards
peptides ending in SLL, SSL, and CVL, and little or no binding to
peptides ending in SKL or SRM, which represent together with SLL the
preferred binding partners of AD-Pex5p. In general, the values
obtained with the TPR containing fragments were higher than those
obtained with the full-length proteins, which may represent a
variation in the expression levels or stabilities of the corresponding
AD-fusion proteins. However, the conclusion that Pex5p and Pex5Rp
display different afﬁnities for C-terminal endings in the employed
assay system remains.Fig. 4. Molecular modelling of the Pex5Rp interaction (A) Overlay of the backbone
structures of the TPR domains of Pex5p (green) and Pex5Rp (red). Amino acids of Pex5p
interacting with the PTS1 peptide YQSKL (blue) as described in [7] are indicated. Those
amino acids that differ between Pex5p and Pex5Rp are boxed. (B) Interactions between
the PTS1 peptide YQSKL (blue) and the amino acids of Pex5p (white and green) and
Pex5Rp (white and red). Those amino acids involved in the PTS1 interaction that don't
differ between Pex5p and Pex5Rp are indicated in white. Different amino acids are
represented in green (Pex5p) and red (Pex5Rp): Lys (Pex5p) and Arg (Pex5Rp) on the
left, Glu and Ser (Pex5p) and Thr and Gly (Pex5Rp) on the right.
868 M. Fransen et al. / Biochimica et Biophysica Acta 1783 (2008) 864–873In previous experiments [16] employing blot-overlay assays and
rat liver proteins, Pex5p and Pex5Rp seemed to recognize the same
set of PTS1-containing proteins. To resolve this issue, the PTS1
peptides Sc02, Hs35, Hs54 and Hs62 (see Table 2) were fused to GST,Fig. 5. SLL, the C-terminal tripeptide of Rab8b, can function as a peroxisomal targeting signa
Rab8b variants, were processed for (in)direct ﬂuorescence microscopy 24 h after transfectio
(the exposure time for DAPI was 12 ms). (A–C) Distinct ﬂuorescent staining patterns obse
exposure time) a portion of the protein localizes to peroxisomes, as illustrated by its colocal
tripeptide SLL of Rab8b (ΔSLL) abolishes peroxisomal targeting. (E) An almost exclusive pero
of the outlined regions. Bars: 20 µm.and binding to the TPR domains of Pex5p and Pex5Rp was
investigated. As shown in Fig. 1A, peptides Hs35 (ending in SRM)
and Hs62 (ending in SSL) gave rise to an interaction with Pex5p or
Pex5Rp only, respectively, matching the two-hybrid results. However,l in CHO cells. CHO cells, transiently transfected with plasmids encoding the indicated
n. Images of each channel were acquired separately with the indicated exposure times
rved for EGFP-Rab8b. Note that in cells expressing high levels of EGFP-Rab8b (= short
ization with the peroxisomal membrane protein Pex14p. (D) Deletion of the C-terminal
xisomal localization is observed with EGFP-Rab8bC204S. The insets show an enlargement
869M. Fransen et al. / Biochimica et Biophysica Acta 1783 (2008) 864–873while Pex5Rp showed no afﬁnity for peptide Sc02 (ending in SKL) and
Pex5p showed very low afﬁnity for peptide Hs54 (ending in SLL) in the
yeast two-hybrid system, both proteins did efﬁciently interact with
the corresponding GST-peptide fusion proteins in a blot-overlay assay
(Fig. 1A). A plausible explanation for this discrepancy is that the
(native) BD-PTS1 and (renatured) GST-PTS1 fusion proteins display
conformational differences.
3.2. Pex5p and Pex5Rp bind the C-terminus of human Rab8b in vitro
As the C-terminus of human Rab8b consists of SLL which might be
recognized by Pex5p and Pex5Rp (Table 2, Fig. 1A, and [32]), the
interaction of Rab8b with Pex5p and Pex5Rp was analyzed in more
detail using yeast two-hybrid (Table 3), blot overlay (Fig. 2), and
peptide competition (Fig. 3) assays. In the yeast two-hybrid assay an
interaction was found only between Pex5Rp and HsRab8b, and this
interaction depended on the presence of SLL (Table 3). In contrast, in
the blot overlay and peptide competition assays, bacterially expressed
(His)6-tagged HsRab8b was recognized by both Pex5p and Pex5Rp.
Both interactions depended on the presence of SLL (Fig. 2) and could
be competitively inhibited by a peptide ending in SKL, but not by a
related peptide lacking this C-terminal tripeptide (Fig. 3). Summar-
ized, these results suggest that bacterially expressed HsRab8b con-
tains a C terminal end, which is recognized by TPR domains from both
Pex5p and Pex5Rp. In contrast, in yeast cells only one interaction was
visualized in a transcription-based assay, indicating structural diffe-
rences between bacterially produced interaction partners and pro-
teins expressed in vivo. As (i) CSLL, the C-terminal tetrapeptide of
Rab8b represents a CAAX prenylationmotif [35], and (ii) prenylation of
the cysteine residue in the CAAX box may induce structural changes
and lead to proteolyis of the three C-terminal (AAX) amino acids in
vivo [35,36], we also investigated whether HsRab8bC204S, a prenyla-
tion-defective variant of Rab8b, was able to interact with Pex5p and
Pex5Rp. Pex5p interactedwith HsRab8bC204S and its wild-type version
in a blot-overlay assay (Fig. 2), but not in the yeast two-hybrid assayFig. 6. Peroxisomal import of EGFP-Rab8bC204S is dependent upon the PTS1-receptor Pex5p. C
control (5+/+) and Pex5p-deﬁcient (5−/−) mouse ﬁbroblasts, and processed for direct ﬂuoresc(Table 3). Pex5Rp recognized HsRab8bC204S in both assays (Table 3),
ruling out that the two-hybrid interaction might be compromised by
in vivo modiﬁcation.
3.3. Comparative protein modelling of Pex5p and Pex5Rp
Since the interaction between Pex5p or Pex5Rp and the C-termini
of their partners ismediated through its TPR-containing domain [4,16],
and the crystal structure of the TPR domain of Pex5p in complexwith a
PTS1 peptide [7] or a substrate protein [9,10] has already been charac-
terized, the distinct PTS1-binding afﬁnities of Pex5p and Pex5Rp could
possibly be explained by comparative protein modelling. The C-ter-
minal regions of Pex5p and Pex5Rp contain seven TPR motifs each.
Crystal structure analysis of this domain of Pex5p in complex with
a PTS1 peptide has revealed the presence of two clusters of three
TPRs separated by a hinge region representing the fourth repeat [7].
Modelling of the TPR domain of Pex5Rp using SWISS MODEL [34]
revealed an identical fold of the main chain (Fig. 4A), consistent with
the observed interactions. However, different amino acid side chains
might account for differences between Pex5p and Pex5Rp in their
ability to interactwith C-termini (Fig. 4B). The asparagine residues that
bind the peptide backbone and the C-terminal carboxylate (Asn378,
Asn489, Asn497, and Asn524 in the short isoform of Pex5p [29]) [7] are
conserved, as well as Arg520 of Pex5p which is engaged in a water-
mediated interaction with the carboxylate ion. The amino acid Lys490
of Pex5p, which is also involved in the latter interaction, is replaced by
another basic amino acid, arginine, the inﬂuence of which is not clear.
Almost all residues responsible for the recognition of the C-terminal
tripeptide Ser-Lys-Leu (Glu348, Val374, Thr377, Asn378, Asn489,
Ala493, Tyr508, Asn524, and Ser528 in Pex5p; [7]) are conserved,
except glutamate at position 379 of Pex5p is replaced by a threonine
(at position 407 of Pex5Rp). This probably results in a change of the
pocket formed by the acidic residues (Glu348 and Glu379 in Pex5p) to
which usually the positively charged lysine of the C-terminal tripep-
tide SKL is bound via a water-mediated interaction. Indeed, peptidesonstructs encoding EGFP-PTS1 and EGFP-HsRab8bC204S were transiently transfected into
ence microscopy 24 h after transfection. Bars: 20 µm.
870 M. Fransen et al. / Biochimica et Biophysica Acta 1783 (2008) 864–873with R or K at the penultimate position of the PTS1 do bind weakly to
Pex5Rp (Table 2). Also, a Pex5p variant in which the glutamate at
position 379 was replaced by a threonine generally displayed com-
pared to thewild-type protein amarkedly lower and higher afﬁnity for
proteins ending in -SKL and -SLL, respectively (Table 3). Interestingly, a
Pex5Rp variant inwhich the threonine at position 407was replaced by
glutamate displayed a lower afﬁnity for proteins ending in -SLL, but no
signiﬁcant increase in afﬁnity for proteins ending in -SKL (Table 3).
Although these observations are in line with the hypothesis that
the glutamate at position 379 of Pex5p (or the threonine at position
407 of Pex5Rp) is important for recognition of proteins with positi-
vely charged (or non-charged) residues at the penultimate position ofFig. 7. Localization of Rab8bvariants and Pex5Rp or Pex5p upon co-expression in CHO cells. CH
and (A) Flag-Pex5Rp or (B) Flag-Pex5p. After 24 h, the cells were ﬁxed and processed for ﬂuoC-terminal endings, they also indicate that other amino acids involved
in interactions with residues upstream of the ultimate tripeptide may
modulate binding. For instance, the serine at position 380 of Pex5p,
which is thought to form hydrogen bonds with the fourth last amino
acid, is replaced by a glycine in Pex5Rp, a substitution which is also
found in S. cerevisiae Pex5p.
3.4. The C-terminus of human Rab8b can function as a PTS1 in vivo
In order to investigatewhether the C-terminal tripeptide of HsRab8b
can function as a PTS1 in vivo, CHO cells were transfectedwith plasmids
coding for EGFP-HsRab8b or EGFP-HsRab8bΔSLL. Cells expressing theseOcellswere transiently transfectedwith plasmids encoding the indicatedRab8bvariants
rescence analysis. The insets show an enlargement of the outlined regions. Bars: 20 µm.
871M. Fransen et al. / Biochimica et Biophysica Acta 1783 (2008) 864–873proteins exhibited distinctiveﬂuorescent stainingpatterns ranging from
apunctate and/or tubular cytoplasmic to perinuclear staining (Fig. 5A–C,
left column). Interestingly, in cells which express high levels of EGFP-
HsRab8b (image data corresponding to short exposure times) some of
the punctate structures observed were peroxisomes, as illustrated by
their colocalization with the peroxisomal marker protein Pex14p
(inserts Fig. 5C). As this peroxisomal staining pattern was never seen
with EGFP-HsRab8bΔSLL (inserts Fig. 5D), these observations show that
the C-terminus of human Rab8b can function as a PTS1 in vivo. In order
to investigatewhether the inefﬁcient targeting of Rab8b to peroxisomes
was the result of a CAAX box-mediated processing step, we also exa-
mined the subcellular localization of EGFP-HsRab8bC204S. Interestingly,
we found that this protein localized almost exclusively toperoxisomes in
wild-type CHO cells (Fig. 5E). Similarly, in mouse ﬁbroblasts a punctate
staining representative of peroxisomal localization was observed,
whereas in Pex5p-deﬁcient mouse ﬁbroblasts EGFP-HsRab8bC204S
gave rise to a diffuse cytosolic staining pattern (Fig. 6). These obser-
vations provide additional evidence that a single amino acid change
outside the C-terminal tripeptide has the potential to strongly inﬂuence,
either directly or indirectly, recognition by Pex5p.
3.5. Rab8b can act as a membrane-recruitment factor for Pex5Rp, but not
Pex5p
Pex5Rp was observed to be recruited to membrane structures
through binding to Rab8b [17]. Therefore, we investigated whether thisFig. 8. Effect of overexpression of Pex5Rp on the import efﬁciency of DsRed-KSKL and DsR
DsRed-KSKL or DsRed-RSLL and EGFP-HsPex5Rp (⁎5R) or HsPex5Rp-EGFP (5R⁎). After 24 h,
localization of DsRed-fusion proteins was determined by its punctate (peroxisomal) or diffuse
results of a representative experiment using HsPex5Rp-EGFP (5R⁎) are shown.small GTPase could also function as a membrane-recruitment factor for
Pex5p. CHO cells were co-transfected with constructs coding for EGFP-
Rab8b or EGFP-Rab8bΔSLL and Flag-Pex5p or Flag-Pex5Rp, and the sub-
cellular distribution pattern of the ectopically expressed fusion proteins
was analyzed by ﬂuorescence microscopy. While Rab8b was able to
recruit Pex5Rp to punctate and/or tubular cytoplasmic structures as
expected (Fig. 7A, upper panels), this protein failed to recruit Pex5p to
such structures (Fig. 7B, upper panels). Interestingly, membrane recruit-
ment of Pex5Rp seemed to be controlled by the C-terminus of Rab8b
(Fig. 7A, middle panels). This observation is in agreement with the
results presented in Fig. 2 and Table 3, and suggests that (non-pre-
nylated) Rab8b is a substrate for Pex5Rp, but not Pex5p, in vivo. In
combinationwith the results presented in Table 2 (e.g. compare Sc01 to
Hs04 for the ending –SKL), one may speculate that a cysteine imme-
diately upstreamof C-terminal tripeptidyl endings is quite unfavourable
for Pex5p, but not Pex5Rp. This hypothesis is in linewith the observation
that Rab8bC204S is a substrate for Pex5p inwild-type cells (Fig. 5E, Fig. 6)
and can be retained in the cytosol upon overexpression of Pex5p (Fig. 7B,
lower panels). Note that also Pex5Rp is able to retain Rab8bC204S in the
cytosol (Fig. 7A, lower panels).
3.6. Effect of overexpression of Pex5Rp on PTS1 protein import
As the results presented above suggest that Pex5p and Pex5Rp may
compete for binding to PTS1-like termini of proteins in vivo, we co-
expressed EGFP-tagged Pex5Rp fusion proteins with either DsRed-KSKLed-RSLL in CHO cells. CHO cells were transiently transfected with plasmids coding for
the cells were ﬁxed and processed for direct ﬂuorescence analysis. (A) The subcellular
(cytosolic) staining pattern in at least 100 cells, and the results were quantiﬁed. (B) The
872 M. Fransen et al. / Biochimica et Biophysica Acta 1783 (2008) 864–873or DsRed-RSLL in CHO cells, and studied the effect of overexpression of
the green ﬂuorescent proteins on the subcellular localization of the red
ﬂuorescent reporter proteins (Fig. 8). When expressed alone DsRed-
KSKL or DsRed-RSLL were associated with peroxisomes in almost all
cells. Simultaneous overexpression of EGFP-tagged Pex5Rp had only
little effect on the subcellular localization of DsRed-KSKL, but resulted in
a diffuse cytosolic staining pattern of DsRed-RSLL in approximately half
of the cells. These observations provide additional support for the
hypothesis that Pex5Rp may interfere with PTS1-dependent import of
proteins in vivo, especially with those not ending in the canonical -SKL.
4. Discussion
Human Pex5Rp was shown to bind to peroxisomal proteins and to
C-termini ending in the prototypical PTS1 tripeptide –SKL [16],
although the corresponding rat orthologue did not [17]. The aim of
this work was to study the interaction of Pex5Rp with C-termini in
more detail and to compare which ones the human Pex5p and Pex5Rp
can bind. By applying blot overlay, yeast two-hybrid, and in vivo co-
expression assays, we showed that the binding speciﬁcities of Pex5Rp
and Pex5p are different. In addition, we demonstrated that the gluta-
mate at position 379 of Pex5p (or the threonine at position 407 of
Pex5Rp) is important for recognition of proteins with positively char-
ged (or non-charged) residues at the penultimate position of PTS1-like
C-terminal endings. With respect to the employed binding assays, it
should be noted that the results obtained by far Western analysis do
not always corroborate those obtained from ‘in vivo’ experiments. This
may not be so surprising taking into account that the context of the C-
terminus exerts a great impact on its ability to interact with Pex5Rp or
Pex5p ([32] and this work), and the conformation of C-termini of
native proteins can be expected to differ from those of the corres-
ponding denatured proteins. Why Chen et al. [17] did not observe any
interaction between Pex5Rp and GST-SKL remains unclear. The most
likely explanation is that the amino acids immediately upstream of
SKL prevent binding. However, as this experimental detail is lacking,
this can not be veriﬁed.
The rat orthologue of Pex5Rp has been described as a TPR-con-
taining Rab8b-interacting protein (TRIP8b) [17]. Rab8b contains a
typical C-terminal CaaX prenylation motif, CSLL. As the C-terminal
tripeptide SLL can act as a PTS1 [32], we investigated whether expres-
sion of EGFP-HsRab8b in CHO cells resulted in a peroxisomal loca-
lization. In most cells, this protein was predominantly localized to as-
yet-unidentiﬁed cytoplasmic membrane structures largely mimicking
the pattern reminiscent of that reported for myc-tagged rat Rab8b in
rat basophilic leukaemia RBL.2H3, neuroblastoma PC12, and AtT-20
neuroendocrine cells [17,18]. However, in a minority of cells EGFP-
Rab8b was also partially associated with peroxisomes. Likely, some
portion of the (overexpressed) wild-type HsRab8b escaped prenyla-
tion and was mistargeted to peroxisomes in a Pex5p-dependent man-
ner. This observation suggests that, if prenylation and proteolysis are
prevented, the C-terminal tripeptide of Rab8b can act as a PTS1. This
hypothesis is in line with our observation that HsRab8bC204S, a pre-
nylation deﬁcient variant, is almost exclusively associated with pero-
xisomes. Whether a portion of HsRab8b is targeted to peroxisomes
under physiological conditions remains to be investigated. If the
amount of unprenylated Ras and Ras-related proteins is negligible in
vivo, the majority of Rab8b will not be localized to peroxisomes. In
addition, it is very likely that the cysteine immediately upstream of the
C-terminal tripeptide SLL plays a crucial role in favouring an inter-
action with Pex5Rp compared to Pex5p. Moreover, other recognition
eventsmay contribute to the binding speciﬁcity in vivo. For example, it
may be that the interactions studied here are modulated by Rabin 8,
another Rab8b binding protein. Rabin 8 is a Rab8-speciﬁc GDP/GTP
exchange factor involved in actin remodelling and polarized mem-
brane transport [37]. In addition, Rabin 8 was found to recruit a large
protein complex, the BBSome, to the centrosome and to activate Rab8leading to docking and fusion of vesicles near the ciliary membranes
[38].
Related to the HCN1 and TRIP8b interaction, it is interesting to note
that this binding is dependent on SNL, the C-terminal tripeptide ofmouse
HCN1 [20]. Previously, we have shown that this C-terminal tripeptide –
being also present in the human peroxisomal enzyme D-aspartate oxi-
dase – can function as a PTS1, and that its peroxisome targeting efﬁciency
becomes higher when preceded by a positively charged residue [22]. As
such a positively charged residue is absent in HCN1 (which ends in ASNL)
and this transporter is most likely transported to the plasma membrane
via the secretorypathway [39],HCN1 isunlikely tobe recognizedbyPex5p
in vivo. On the other hand, this illustrates again the similarities in the
binding folds of the TPR domains of Pex5Rp/TRIP8b and Pex5p.
The absence of a well-deﬁned gene-related phenotype (e.g. a patient
cell line, a mouse model, or a deletion strain of the yeast orthologue)
makes it difﬁcult to deﬁne a functional role for Pex5Rp. However, the
observations that (i) endogenous Pex5Rp/TRIP8b and HCN1 colocalize
within dendritic arbors of hippocampal CA1 and neocortical layer V
pyramidal neurons, (ii) the labeling of Pex5Rp/TRIP8b largely disappears
in HCN1 knockoutmice, and (iii) Pex5Rp/TRIP8b drastically decreases the
surface expression of HCN protein, provide strong evidence that Pex5Rp/
TRIP8b is involved in controlling HCN channel density in the plasma
membrane [20]. In addition, the recent observation that Pex5Rp/TRIP8b
can interactwith latrophilin, amemberof the secretin familyofG-protein-
coupled receptors, provides support for the hypothesis that Pex5Rp/
TRIP8b may play a more general role in the trafﬁcking pathway from the
plasma membrane to endosomes for a select set of membrane proteins
[21]. Theseﬁndings, togetherwith ourobservations that Pex5Rp/TRIP8b is
(almost exclusively) expressed in brain and does not interact with other
peroxins [16], make it unlikely that Pex5Rp/TRIP8b possesses a peroxi-
some-related function. Nevertheless, our observations that this protein
can compete with Pex5p for PTS1-binding in vitro and is able to retain a
peroxisomal reporter protein in the cytosol upon overexpression in CHO
cells, suggest that the PTS1-protein import efﬁciency in a cell may be
affected by altered Pex5Rp protein expression levels.
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